entertainment -WSS

entertainment

author：explore 2025-09-06 08:25:00 - browse：39

Eli Lilly headquarters — Kristoffer Tripplaar/AP

Eventually, the luckiest companies get to deal with a very particular problem: what to do when their stock could be getting ahead of itself.

It’s a problem Eli Lilly got a little taste of Tuesday when it announced its full-year earnings. The drugmaker’s stock has more than doubled over the past 12 months due to the ever-increasing hopes for its GLP-1-based diabetes and weight loss drug, sold under the brand names Mounjaro and Zepbound. It was a big deal when Lilly became the first drug company ever to have a market value of $500 billion; it’s now sitting at a stunning $670 billion.

At first, the earnings report suggested the company had blasted through expectations again, announcing fourth-quarter 2023 sales of $9.35 billion, almost half a billion dollars above analysts’ expectations, and also announcing new data for Mounjaro in treating metabolic dysfunction-associated steatohepatitis (MASH), a form of liver disease previously called NASH. Initially, shares traded up 5%.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Health care needs a new profession: neuroimaging counseling

WSS

Cholera vaccine supply gets boost as demand surges globally

Dexcom's push to bring CGM to type 2 diabetes patients

Health care needs a new profession: neuroimaging counseling

UpToDate has a racism problem: Dr. Stanley Goldfarb

UpToDate has a racism problem: Dr. Stanley Goldfarb

Fatty liver disease was alleviated by Lilly’s ‘triple

entertainment

entertainment

entertainment

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Security flaws in third

Dobbs anniversary: the lost opportunity of abortion as health care

More tobacco lobbyists active in statehouses

Alkermes shareholders re

Bird flu outbreak in cows is latest avian flu curveball

Wildfire smoke exposes gaps in outdoor worker protections

Drug cartel violence flares in western Mexico after vigilante leader's killing

Novavax promises a turnaround & Lilly roils the obesity market

Diversity in clinical trials starts with building trust, experts say

explore

Health care needs a new profession: neuroimaging counseling

MultiPlan and major insurers sued for alleged medical price

Bird flu outbreak in cows is latest avian flu curveball

FTC falls short on scrutinizing hospital mergers, study says

Cell therapy fails to slow type 1 diabetes, but safety is established

H5N1 bird flu found in pasteurized milk: what we know

focus

explore

explore

knowledge